Group Leader
                                            Carlos Molina Cateriano                                        
                                            Principal Investigator (PI)
                                            Estela Sanjuan, Marta Rubiera, David Rodríguez, Estefania Montiel, Jorge Pagola, Manuel Requena, Marc Ribó, Marta Olivé, María Ángeles Muchada                                        
                                            Researchers
                                            Alejandro Tomasello, Jesús Juega, Jiahui Li, Noelia Rodríguez, Olalla Pancorbo                                        
                                            PhD Students
                                            Federica Rizzo, María Belén Taborda, Pere Canals                                        
                                        Nursing and Technical Staff
                                            Claudia Meza, María Victoria Sala, Carole Conforti, Cristina Losada, David Cano, Ester Sánchez, Judith Cendrero, Lidia García, Marc Molina, María Baladas, Cristina Guirao, Carolina Paredes, Riccardo Tiberi, Maria Franco, Jordi Brunet                                        
50
PUBLICATIONS
58.0%
%Q1
1,089
IMPACT FACTOR
21.78
AVERAGE IMPACT FACTOR
SELECTED ARTICLES
                                                        Pérez de la Ossa N, Abilleira S, Jovin TG, García-Tornel Á, Jimenez X, Urra X, Cardona P, Cocho D, Purroy F, Serena J, San Román Manzanera L, Vivanco-Hidalgo RM, Salvat-Plana M, Chamorro A, Gallofré M, Molina CA, Cobo E, Davalos A, Ribo M
                                                        Effect of Direct Transportation to Thrombectomy-Capable Center vs Local Stroke Center on Neurological Outcomes in Patients With Suspected Large-Vessel Occlusion Stroke in Nonurban Areas: The RACECAT Randomized Clinical Trial
                                                        JAMA. 2022 May 10;327(18):1782-1794
                                                        DOI: doi: 10.1001/jama.2022.4404
                                                        IF: 157.375
                                                    
                                                        Renú A, Millán M, San Román L, Blasco J, Martí-Fàbregas J, Terceño M, Amaro S, Serena J, Urra X, Laredo C, Barranco R, Camps-Renom P, Zarco F, Oleaga L, Cardona P, Castaño C, Macho J, Cuadrado-Godía E, Vivas E, López-Rueda A, Guimaraens L, Ramos-Pachón A, Roquer J, Muchada M, Tomasello A, Dávalos A, Torres F, Chamorro Á
                                                        Effect of Intra-arterial Alteplase vs Placebo Following Successful Thrombectomy on Functional Outcomes in Patients With Large Vessel Occlusion Acute Ischemic Stroke: The CHOICE Randomized Clinical Trial
                                                        JAMA. 2022 Mar 1;327(9):826-835
                                                        DOI: doi: 10.1001/jama.2022.1645
                                                        IF: 157.375
                                                    
                                                        Jovin TG, Li C, Wu L, Wu C, Chen J, Jiang C, Shi Z, Gao Z, Song C, Chen W, Peng Y, Yao C, Wei M, Li T, Wei L, Xiao G, Yang H, Ren M, Duan J, Liu X, Yang Q, Liu Y, Zhu Q, Shi W, Zhu Q, Li X, Guo Z, Yang Q, Hou C, Zhao W, Ma Q, Zhang Y, Jiao L, Zhang H, Liebeskind DS, Liang H, Jadhav AP, Wen C, Brown S, Zhu L, Ye H, Ribo M, Chang M, Song H, Chen J, Ji X
                                                        Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion
                                                        N Engl J Med. 2022 Oct 13;387(15):1373-1384
                                                        DOI: doi: 10.1056/NEJMoa2207576
                                                        IF: 176.082
                                                    
                                                        Fischer U, Kaesmacher J, Strbian D, Eker O, Cognard C, Plattner PS, Bütikofer L, Mordasini P, Deppeler S, Pereira VM, Albucher JF, Darcourt J, Bourcier R, Benoit G, Papagiannaki C, Ozkul-Wermester O, Sibolt G, Tiainen M, Gory B, Richard S, Liman J, Ernst MS, Boulanger M, Barbier C, Mechtouff L, Zhang L, Marnat G, Sibon I, Nikoubashman O, Reich A, Consoli A, Lapergue B, Ribo M, Tomasello A, Saleme S, Macian F, Moulin S, Pagano P, Saliou G, Carrera E, Janot K, Hernández-Pérez M, Pop R, Schiava LD, Luft AR, Piotin M, Gentric JC, Pikula A, Pfeilschifter W, Arnold M, Siddiqui AH, Froehler MT, Furlan AJ, Chapot R, Wiesmann M, Machi P, Diener HC, Kulcsar Z, Bonati LH, Bassetti CL, Mazighi M, Liebeskind DS, Saver JL, Gralla J
                                                        Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial
                                                        Lancet. 2022 Jul 9;400(10346):104-115
                                                        DOI: doi: 10.1016/S0140-6736(22)00537-2
                                                        IF: 202.731
                                                    
                                                        Jovin TG, Nogueira RG, Lansberg MG, Demchuk AM, Martins SO, Mocco J, Ribo M, Jadhav AP, Ortega-Gutierrez S, Hill MD, Lima FO, Haussen DC, Brown S, Goyal M, Siddiqui AH, Heit JJ, Menon BK, Kemp S, Budzik R, Urra X, Marks MP, Costalat V, Liebeskind DS, Albers GW
                                                        Thrombectomy for anterior circulation stroke beyond 6 h from time last known well (AURORA): a systematic review and individual patient data meta-analysis
                                                        Lancet. 2022 Jan 15;399(10321):249-258
                                                        DOI: doi: 10.1016/S0140-6736(21)01341-6
                                                        IF: 202.731
                                                    
                                            HARMONICS. Harmonization and Implementation of High Value Stroke Care
                                            Principal Investigator: Carlos Molina
                                                                                            Agency: European Commission
                                                                                                                                        Funding: 468,090€
                                                                                                                                        Period: 01/01/2022 - 31/12/2024
                                                                                    
                                            Clinical trial to evaluate the administration of ApTOLL in ambulances and the neuroprotective effect in stroke patients. RACETOLL
                                            Principal Investigator: Marc Ribó
                                                                                            Agency: Ministerio de Ciencia e Innovación-MICINN
                                                                                                                                        Funding: 437,334€
                                                                                                                                        Period: 01/03/2022 - 28/02/2025
                                                                                    
                                            : RES-Q PLUS: Comprehensive solutions of healthcare improvement based on the global Registry of Stroke Care Quality
                                            Principal Investigator: Carlos Molina
                                                                                            Agency: European Commission
                                                                                                                                        Funding: 396,730€
                                                                                                                                        Period: 01/10/2022 - 30/09/2026
                                                                                    
                                            Ensayo Clínico para evaluar biomarcadores de efecto neuroprotector de ApTOLL en pacientes de Ictus Isquémico Agudo
                                            Principal Investigator: Marc Ribó
                                                                                            Agency: Ministerio de Ciencia e Innovación-MICINN
                                                                                                                                        Funding: 391,911.2€
                                                                                                                                        Period: 01/10/2020 - 31/03/2023
                                                                                    
                                            VALIDATE: Validation of a Trustworthy AI-based Clinical Decision Support System for Improving Patient Outcome in Acute Stroke Treatment
                                            Principal Investigator: Marta Rubiera
                                                                                            Agency: European Commission
                                                                                                                                        Funding: 567,950€
                                                                                                                                        Period: 01/05/2022 - 30/04/2026